Showing 1,301 - 1,320 results of 1,436 for search '"Cancer staging"', query time: 0.14s Refine Results
  1. 1301

    Perioperative Complications and Oncologic Outcomes after Radical Cystectomy in End-Stage Renal Disease Patients with Bladder Cancer Obtained Using a Standardized Reporting System by Yu-Liang Liu, Chun-Te Wu, Yu-Chao Hsu, Miao-Fen Chen, Chih-Shou Chen, Chung-Sheng Shi, Yun-Ching Huang

    Published 2022-07-01
    “…According to multivariate analysis with the Cox hazards regression, male sex, age > 70 years, CCI ≥ 5, bladder cancer stage ≥ 3, lymphovascular invasion, and experiencing major complications were significant poor prognostic factors for overall survival (all, <i>p</i> < 0.05). …”
    Get full text
    Article
  2. 1302

    Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer by Yang Tan, Li-juan Feng, Ying-he Huang, Jia-wen Xue, Zhen-Bo Feng, Li-ling Long

    Published 2024-03-01
    “…Abstract Objective This study aimed to develop and validate an artificial intelligence radiopathological model using preoperative CT scans and postoperative hematoxylin and eosin (HE) stained slides to predict the pathological staging of gastric cancer (stage I-II and stage III). Methods This study included a total of 202 gastric cancer patients with confirmed pathological staging (training cohort: n = 141; validation cohort: n = 61). …”
    Get full text
    Article
  3. 1303

    Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis by Pedro Luiz Serrano Uson Junior, Leonardo Carvalho, Milena Lourenço Coleta Fernandes, Gehan Botrus, Rodrigo de Souza Martins, Elaine Ferreira da Silva, Sarah Silva Mello Batista dos Santos, Leticia Taniwaki, Patrícia Taranto, Ana Carolina Pereira Dutra, João Bosco de Oliveira Filho, Sergio Eduardo Alonso Araujo, Fernando Moura

    Published 2022-08-01
    “…On multivariable analysis in pancreatic cancer stages I and II, including age, sex, borderline or resectable disease, CA 19–9, positive lymph nodes and neoadjuvant treatment, the surgery was the only factor associated with improved overall survival (p = 0.04). …”
    Get full text
    Article
  4. 1304

    Factors influencing the 5-year survival rate of oral cancer patients in the Mongolian population: a retrospective cohort study by Oyuntsetseg Davaatsend, Munkhdul Altannamar, Badral Batbayar, Urjinlkham Jagdagsuren

    Published 2023-12-01
    “…Survival analysis was conducted using the Kaplan–Meier method, and STATA was used for statistical analysis.ResultsThe study revealed a 5-year survival rate of 50.3% for oral cancer patients, with a survival rate of 38% for tongue cancer patients. Age, residence, cancer stage, and cancer recurrence were identified as significant survival predictors. …”
    Get full text
    Article
  5. 1305

    Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan by Haque R, Chen LH, Oestreicher N, Lalla D, Chlebowski RT

    Published 2023-08-01
    “…We examined the risk of subsequent breast cancer in women with HER-2 positive disease, and the impact of trastuzumab use, in a large California community-based health plan.Patients and Methods: A cohort of 3550 women with HER2-positive breast cancer (stages I–III) from 2009– 2017 were followed through December 2018. …”
    Get full text
    Article
  6. 1306
  7. 1307

    Association of <i>VEGFA</i> gene rs2010963 polymorphism with cervical cancer and its progression by Artem V. Rogalev, Maria S. Kishenya, Svetlana V. Pishchulina, Evgeniy V. Khomutov

    Published 2023-12-01
    “…Materials and methods: This case-control study included 120 women (aged 49 [42; 65] years) with cervical cancer stage I-II and 112 women without cervical or other types of cancer. …”
    Get full text
    Article
  8. 1308

    Racial Disparity Among Women Diagnosed With Invasive Breast Cancer in a Large Integrated Health System by Maharaj Singh, Santhi D. Konduri, George C. Bobustuc, Amin B. Kassam, Richard A. Rovin

    Published 2018-07-01
    “…This study examined the effects of demographics, biomarkers, tumor characteristics, cancer stage, morphology, and treatment variables on overall and cancer-free survival in these patient populations. …”
    Get full text
    Article
  9. 1309

    Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 Variants by Aslı Subaşıoğlu, Zeynep Gülsüm Güç, Emine Özlem Gür, Mustafa Agah Tekindal, Murat Kemal Atahan

    Published 2023-01-01
    “…Detailed information about the patients (age of diagnosis, family history, gender), cancer stage, tumour characteristics (ER, PR, human epidermal growth factor receptor 2 status) and all information related to the detected variants (gene, location, nucleotide and amino acid change, exon number, impact, mutation classification, dbSNP number and HGMD variant class) were assessed. …”
    Get full text
    Article
  10. 1310

    <i>POFUT1</i> as a Promising Novel Biomarker of Colorectal Cancer by Julien Chabanais, François Labrousse, Alain Chaunavel, Agnès Germot, Abderrahman Maftah

    Published 2018-10-01
    “…<i>POFUT1</i> overexpression is markedly associated with rectal location, non-mucinous adenocarcinoma and cancer stages IV and M1. <i>NOTCH1</i> overexpression is only associated with rectal location and non-mucinous adenocarcinoma. …”
    Get full text
    Article
  11. 1311

    Association between dietary inflammatory index and body fat percentage among newly diagnosed breast cancer patients by Wai Han Ng, Zalina Abu Zaid, Barakatun Nisak Mohd Yusof, Syafinaz Amin Nordin, Poh Ying Lim

    Published 2023-12-01
    “…E-DII was positively associated with body fat percentage (OR 2.952; 95% CI 1.154–7.556; p = 0.024) and remained significant after adjustment for cancer stage, age, physical activity, ethnicity, smoking history, and presence of comorbidities. …”
    Get full text
    Article
  12. 1312

    Quality of Life and Associated Factors Among Adult Cancer Patients Undergoing Chemotherapy Treatment at Amhara National, Regional State, Ethiopia, 2021 by Ahmed Nuru Muhamed MSc, Sitotaw Kerie Bogale MSc, Henok Biresaw Netere MSc

    Published 2023-05-01
    “…Emotional functioning, social functioning, nausea and vomiting, pain, financial difficulty, education, body mass index, cancer stage, chemotherapy cycle, comorbidity, anxiety, and depression all had association with QoL. …”
    Get full text
    Article
  13. 1313

    CD71+ erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors by Isobel Okoye, Shokrollah Elahi, Najmeh Bozorgmehr, John Walker, Julia Lu, Siavash Mashhouri, Petya Koleva

    Published 2023-05-01
    “…Lastly, we found a higher frequency of CECs in the blood circulation at the later cancer stage and their abundance was associated with anemia, and a poor response to immunotherapy. …”
    Get full text
    Article
  14. 1314

    LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression [Retraction] by Zhao D, Zhang H, Long J, Li M

    Published 2023-10-01
    “…Onco Targets Ther. 2020;13:2957&#x2013;2972. https://doi.org/10.2147/OTT.S232839; Wang Y, Yin Y, Zhou H, Cao Y. miR&#x2011;639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma. …”
    Get full text
    Article
  15. 1315

    A Dual‐Filtration System for Single‐Cell Sequencing of Circulating Tumor Cells and Clusters in HCC by Vincent L. Chen, Qianhui Huang, Ramdane Harouaka, Yuheng Du, Anna S. Lok, Neehar D. Parikh, Lana X. Garmire, Max S. Wicha

    Published 2022-06-01
    “…Median age was 64 years old; 7 of 8 were male; and 7 of 8 had and Barcelona Clinic Liver Cancer stage C. We performed scRNAseq of 38 CT cells and 33 clusters from these patients. …”
    Get full text
    Article
  16. 1316

    Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases by Yu Miyama, Tomomi Kato, Masayasu Sato, Akira Yabuno, Kosei Hasegawa, Masanori Yasuda

    Published 2024-01-01
    “…Biopsy specimens confirmed squamous cell carcinoma with a 2018 International Federation of Gynecology and Obstetrics (FIGO) uterine cervical cancer stage of IB2. In a subsequent conization specimen, the tumor appeared exophytic. …”
    Get full text
    Article
  17. 1317
  18. 1318

    Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy by Piotr Kryst, Sławomir Poletajew, Aleksandra Wyczałkowska-Tomasik, Stefan Gonczar, Maciej Wysocki, Renata Kapuścińska, Wojciech Krajewski, Wojciech Zgliczyński, Leszek Pączek

    Published 2020-10-01
    “…Status of viral infections had no influence on the clinical cancer stage, surgical procedure or survival. Conclusions: EBV and ADV infections are common in renal cancer patients and increase the risk of high-grade RCC presence. …”
    Get full text
    Article
  19. 1319

    SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer by Daniel L. Hess, Christian Harmon, Smita Bhatia, Grant R. Williams, Smith Giri

    Published 2023-11-01
    “…Finally, we computed the impact of SARC‐F and CT measures on overall survival using Kaplan–Meier curves and Cox regression models, after adjusting for age, sex, cancer type, and cancer stage. Results We identified 212 older adults with a median age of 68.8 years; with 60.8% males, 76.6% whites, and pancreatic cancer (21.2%) being the most common malignancy. …”
    Get full text
    Article
  20. 1320

    HUBUNGAN ANTARA STATUS KLINIKOPATOLOGI PADA PENDERITA KANKER PAYUDARA LANJUT LOKAL YANG MENJALANI MASTEKTOMI RADIKAL MODIFIKASI PASCA KEMOTERAPI NEOAJUVAN DENGAN REKURENSI LOKOREGI... by , RADITYO PRASTOATMOJO, , dr. Kunta Setiadji, SpB(K)Onk.

    Published 2014
    “…Approximately 10-20% of patients, breast cancer stage I - IIIA experienced local and/or regional recurrence within 10 years after mastectomy. …”
    Thesis